Search

everythinglearnresearchcommunity

for

Search:↓

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

TGF-β is crucial for controlling stem cell behavior and changes in its signaling can lead to diseases like cancer.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Finasteride effectively treats hidradenitis suppurativa for most patients.

Exosomes from dermal papilla cells help hair growth by making hair follicle stem cells multiply and change.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Both mouse and rat models are effective for testing alopecia areata treatments.

Adenosine helps human hair grow and prevents hair loss by targeting specific cells.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.